跳到主要內容

Khurshid Jamal 的 Form 4 申報

Nukkleus Inc.(NUKK),2022/2/17 申報

申報編號
0001213900-22-008266
申報時間
2022/2/17
交易日
2021/5/24-8/30
申報延遲
269 天遲報
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 2 筆非衍生性交易。交易後 269 天才申報,超過 2 個營業日的期限。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Khurshid JamalCIK 0001874585高階主管(營運長)、持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2021/8/30Common Stock, $0.0001 par value per shareP買進取得+11,119,792–F1–37,103,411直接
2021/5/24Common Stock, $0.0001 par value per shareP買進取得+37,069–F1–25,983,249直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

On May 24, 2021, Nukkleus Inc. (the "Company") and the shareholders of Match Financial Limited (the "Match Shareholders"), a private limited company formed in England and Wales ("Match"), entered into a Purchase and Sale Agreement (the "Match Agreement"), pursuant to which the Company, on May 28, 2021, acquired 1,152 ordinary shares of Match representing 70% of the issued and outstanding ordinary shares of Match in consideration of 70,000,000 shares of common stock of the Company (the "Initial Transaction") and issued an option to acquire the balance of Match's outstanding ordinary shares in consideration of 100,000 shares of common stock of the Company. On August 30, 2021, the Company exercised its option pursuant to which it acquired from the Match Shareholders the balance of 493 ordinary shares of Match representing 30% of the issued and outstanding ordinary shares of Match for an additional 30,000,000 shares of common stock of the Company.

表 I 有 2 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)